WallStreetZenWallStreetZen

NASDAQ: TARA
Protara Therapeutics Inc Stock Ownership - Who owns Protara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Protara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard S. LevyDirector2025-05-1420,000$3.19
$63.80kBuy
Richard S. LevyDirector2025-05-1420,000$3.19
$63.80kBuy
Richard S. LevyDirector2025-05-1420,000$3.19
$63.80kBuy
Jacqueline ZummoChf Scientific Operations Off2025-03-2621,224$4.53
$96.14kSell
Patrick FabbioChief Financial Officer2025-01-213,061$4.76
$14.57kSell
Hannah FryVP Controller2025-01-212,130$4.76
$10.14kSell
Jesse SheffermanCEO and President2025-01-2115,469$4.76
$73.63kSell
Jacqueline ZummoChf Scientific Operations Off2025-01-216,554$4.76
$31.20kSell
Hannah FryVP Controller2025-01-03394$6.14
$2.42kSell
Jacqueline ZummoChf Scientific Operations Off2025-01-032,157$6.14
$13.24kSell

1 of 4

TARA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARA insiders and whales buy or sell their stock.

TARA Shareholders

What type of owners hold Protara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hubert Birner14.60%5,632,802$17.69MInsider
Abingworth LLP10.79%4,162,389$13.07MInsider
Tvm Life Science Ventures VI Gmbh Co Kg9.97%3,846,186$12.08MInsider
Janus Henderson Group PLC9.82%3,788,176$11.89MInstitution
John Gordon Freund9.35%3,608,812$11.33MInsider
Ra Capital Management LP8.81%3,400,000$10.68MInstitution
James E. Flynn6.28%2,422,745$7.61MInsider
Timothy Haines5.56%2,144,517$6.73MInsider
Opaleye Management Inc5.16%1,989,134$6.25MInsider
Blackstone Inc4.52%1,744,042$5.48MInstitution

1 of 3

TARA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARA47.68%52.32%Net SellingNet Buying
ELTX9.95%70.40%Net Buying
SEER46.79%52.68%Net SellingNet Selling
GLSI8.19%91.81%Net BuyingNet Buying
CCCC78.03%21.97%Net SellingNet Buying
View Top Biotech Stocks

Protara Therapeutics Stock Ownership FAQ

Who owns Protara Therapeutics?

Protara Therapeutics (NASDAQ: TARA) is owned by 74.54% institutional shareholders, 81.79% Protara Therapeutics insiders, and 0.00% retail investors. Hubert Birner is the largest individual Protara Therapeutics shareholder, owning 5.63M shares representing 14.60% of the company. Hubert Birner's Protara Therapeutics shares are currently valued at $17.69M.

If you're new to stock investing, here's how to buy Protara Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.